CONGRESS SPECIAL

Interview with Professor Sylvie Rottey

Active surveillance in prostate cancer

A. de la Taille

What about oligometastatic therapy in prostate cancer?

Prof. P. Ost, PhD and Prof. B. Tombal

Therapeutic sequencing in prostate Cancer

A. de la Taille

Congress highlights 2018

Dr. D. De Maeseneer, Dr. F-X. Otte and Dr. S. Albisinni

A new treatment paradigm in metastatic bladder cancer: chemotherapy and immune checkpoint inhibition in 2018

Ronald de Wit; MD, PhD

Biomarkers in the era of immunotherapy: lessons learned from lung, bladder and kidney cancer

M. Kockx, MD, PhD

What do we still need to know about the treatment of RCC?

L. Albiges

The continuously evolving treatment landscape in renal cell carcinoma

Viktor Grünwald

Penile cancer

M. Albersen, MD, PhD